<?xml version="1.0" encoding="UTF-8"?>
<ref id="b19-br-0-0-01412">
 <label>19</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>O'Bryant</surname>
    <given-names>SE</given-names>
   </name>
   <name>
    <surname>Edwards</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>LA</given-names>
   </name>
   <name>
    <surname>Hall</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Kuras</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Scherzer</surname>
    <given-names>CR</given-names>
   </name>
  </person-group>
  <article-title>Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study</article-title>
  <source>Alzheimers Dement (Amst)</source>
  <volume>11</volume>
  <fpage>374</fpage>
  <lpage>382</lpage>
  <year>2019</year>
  <pub-id pub-id-type="doi">10.1016/j.dadm.2019.03.001</pub-id>
  <?supplied-pmid 31080873?>
  <pub-id pub-id-type="pmid">31080873</pub-id>
 </element-citation>
</ref>
